A leading pro-life group said it opposed advancing Heidi Overton's nomination to lead the Food and Drug Administration without commitments from the Trump administration on abortion drug policy.
asserted
it → lead → policy
The White House withdrew her nomination this week amid questions about her support in the Senate.
asserted
House → withdraw → Senate
In an interview with Fox News Digital, Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, said his group asked the Senate to hold up Overton’s confirmation until it received "firm commitments" from the administration on two fronts regarding abortion drug policy.
asserted
it → say → policy
Baptist said the group wants the next FDA nominee to commit to ending mail-order access to abortion drugs authorized under the Biden administration and changing how the agency studies the safety of those pills.
asserted
agency → say → pills
"Right now, we’re seeing more abortions in this country than before the Supreme Court’s decision overturning Roe v. Wade," Baptist said.
asserted
Baptist → see → Wade
"That’s precisely because of what the Biden FDA did to authorize mail-order abortion drugs.
asserted
FDA → ’ → drugs
We’re seeing upwards of 15,000 abortion drugs and abortions occurring in pro-life states.
asserted
drugs → see → states
Those states can’t meaningfully enforce their laws while this nationwide policy is in place."
asserted
policy → enforce → place
"Under the Biden-era policy, anybody can obtain these drugs online and receive them through the mail," he continued.
asserted
he → obtain → mail
"When I say anybody, we’ve seen news story after news story every week about men and other predators obtaining these drugs to coerce or poison women into taking them against their will.
asserted
men → say → will
My question to this administration is: How many more women have to be poisoned or coerced with abortion drugs before you take action on this drug?"
asserted
you → have → drug
Under the Biden administration, the FDA eliminated the in-person dispensing requirement for mifepristone, allowing it to be prescribed without an in-person visit by certified prescribers and dispensed by certified pharmacies through the mail.
asserted
it → eliminate → mail
On the group's second point of concern, Baptist said the FDA needs to conduct a new study to show the safety — or lack thereof — of mifepristone.
asserted
FDA → say → mifepristone
"The problem is that the study is significantly flawed," he said.
asserted
he → flaw → ?
"It’s almost designed to fail and not lead to future changes to the drug regimen.
asserted
It → design → regimen
We have asked for more robust data because significant information is currently lacking, including transparency into the agency’s methodology and an invitation for outside experts who have studied this drug over the last few decades.
asserted
who → ask → decades
Everybody should support better data, more transparency and outside experts who can inform an agency that has never conducted such a study before," he added.
asserted
he → support → study
Several pro-life groups and Republican lawmakers have urged the Trump administration to complete the FDA’s safety review of mifepristone and consider reinstating safeguards, while some have called for removing the drug from the market.
asserted
some → urge → market
The FDA said the review is ongoing, with study results expected in December 2026 and a final report expected by March 2027.
asserted
report → say → March
The White House pulled Overton’s nomination to lead the FDA earlier this week, one day before a Senate committee vote.
asserted
House → pull → vote
President Donald Trump picked Overton, a physician and White House advisor, in August to succeed Marty Makary, who resigned from the position in May.
uncertain
who → pick → May
Kyle Diamantas has led the agency in an acting capacity since Makary’s departure.
asserted
Diamantas → lead → departure
Overton also previously served as vice chair and chief policy officer at the America First Policy Institute, a conservative think tank, where she criticized expanded access to abortion pills in a 2023 policy brief.
asserted
she → serve → brief
The White House said Overton lacked the votes on Capitol Hill and pulled her nomination, although Sen. Bill Cassidy, chair of the Senate health committee, contended that he believed she could have been confirmed.
uncertain
she → say → committee
"The White House abandoned a viable confirmation path for Dr. Overton.
asserted
House → abandon → Overton
The WH said that this was because she did not have the votes to pass.
asserted
she → say → votes
This was odd as I was having productive conversations with members," Cassidy, R-La., wrote on X.
asserted
Cassidy → have → X.
"I believe she would have had the votes to pass out of committee and pass the full Senate."
asserted
she → believe → Senate
Baptist said he did not know whether the White House was concerned about pro-life votes or other constituencies but thinks Cassidy "was making progress with the administration to secure the commitments we were seeking and asking the Senate to hold the administration accountable for."
asserted
administration → say → Senate
Cassidy had criticized Overton for supporting Trump’s decision to recommend changes to the childhood vaccine schedule, but the senator said he had been convinced she was right for the job after she committed to "follow the science."
asserted
she → criticize → science
She had appeared alongside Trump in the Oval Office as the president signed an executive order calling for changes to childhood vaccine recommendations, including a recommendation to administer measles, mumps and rubella vaccines separately once individual shots become available domestically.
asserted
shots → appear → vaccines
Cassidy said at a September hearing that there was no scientific evidence for Trump’s suggestion that the combined shot could be "quite lethal" and warned the remark could discourage vaccination.
uncertain
remark → say → vaccination
"Yes, senator, the MMR vaccine is safe and effective," Overton told Cassidy.
asserted
Overton → tell → Cassidy
Pressed on what she would do if Trump asked her to disregard the FDA’s safety standards, Overton said she would give the president her best advice and follow the legal requirements for reviewing individual products.
asserted
she → press → products
Sen. Maggie Hassan, D-N.H., asked Overton directly whether Trump was wrong.
asserted
Trump → ask → Overton
Overton reiterated that the vaccine was safe and effective and called it the best tool available during the measles outbreak.
asserted
vaccine → reiterate → outbreak
Sen. Ed Markey, D-Mass., questioned why she had not corrected Trump in the Oval Office.
asserted
she → question → Office
"Why should we expect you to stand up to the president as FDA commissioner?" Markey asked.
asserted
Markey → expect → commissioner
Baptist said he wants the next FDA commissioner to be somebody who "understands science" and has experience managing an agency.
asserted
who → say → agency
"The FDA is a very large bureaucracy with multiple constituencies, so understanding how science is conducted and how drugs are approved will be essential to any successful candidate or nominee for the position," he said.
asserted
he → understand → position
…and 8 more, not listed.